PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93019C00053 — 19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY…

19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY… is a federal NONE award for Department of Health and Human Services (HHS) held by DUKE UNIVERSITY. Estimated value $79M ($38.2M obligated). Current period of performance ends Sep 15, 2028. Last award drew 2 bidders.

$79M
Estimated Value
$38.2M
Obligated
Sep 15, 2028
PoP End / Expires
2
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

DUKE UNIVERSITY holds $183.3M across 191 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 2 offers. Set-aside status: NONE. Recompete timing centers on the Sep 15, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75N93019C00053
AgencyDepartment of Health and Human Services (HHS)
IncumbentDUKE UNIVERSITY
UEITP7EK8DZV6N5
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12
PoP end (current)Sep 15, 2028
Obligated$38.2M

19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE. THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE SEVERABLE OPTION 2 AND NON-SEVERABLE OPTIONS 27.A AND 34 AND UPDATE VARIOUS

Recompete timing

Public
Expiring in 761 days

Current PoP ends Sep 15, 2028 (761 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 15, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

DUKE UNIVERSITY$183.3M obligated across 191 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($183.3M) · all agencies
Department of Health and Human Services (HHS)$172.3M · 94%Department of Defense (DOD)$4.6M · 3%
Department of the Interior (DOI)$3.9M · 2%
Department of Veterans Affairs (VA)$1.4M · 1%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open DUKE UNIVERSITY’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75N93019C00053?

75N93019C00053 (19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY…) is a Department of Health and Human Services (HHS) award with an estimated value of $79M, currently held by DUKE UNIVERSITY. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75N93019C00053?

DUKE UNIVERSITY is the incumbent with $183.3M across 191 related awards in SCOUT’s public footprint. The current period of performance ends Sep 15, 2028.

When does 75N93019C00053 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 15, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N93019C00053